Neurology News and Research

Latest Neurology News and Research

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration issued a Complete Response Letter for the New Drug Application for dasotraline, a novel dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention-deficit hyperactivity disorder.

3 Sep 2018

Presence of new or worsened bedsores associated with lower quality outcomes for rehab patients

A new study from the University at Buffalo has shown that the presence of new or worsened bedsores is an effective indicator of the quality of care for rehab patients.

31 Aug 2018

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).

30 Aug 2018

Rush University’s Ear, Nose and Throat program ranked top in three-state area

Rush University Medical Center's Ear, Nose and Throat program was ranked higher than any other similar program in Illinois, Indiana and Wisconsin, and 24th in the nation, in U.S. News & World Report's annual "Best Hospitals" issue, published in July.

30 Aug 2018

Study: First independent in-home use of brain-computer interface by ALS patients shows promise

Laboratory studies have shown the potential for patients with amyotrophic lateral sclerosis, who cannot move or speak, to communicate using a brain-computer interface.

30 Aug 2018

SMA treatment may be effective even if started in children seven months and older

A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.

30 Aug 2018

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Johns Hopkins Medicine researchers say new experiments using magnetic pulse brain stimulation on people with moderate to severe restless legs syndrome have added to evidence that the condition is due to excitability and hyperarousal in the part of the brain's motor cortex responsible for leg movement.

29 Aug 2018

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Mount Sinai researchers have discovered that a particular type of cell present in bladder cancer may be the reason why so many patients do not respond to the groundbreaking class of drugs known as PD-1 and PD-L1 immune checkpoint inhibitors, which enable the immune system to attack tumors.

29 Aug 2018

Researchers enlist genes that control production of cellular energy stored in ATP molecules

Everything the body does--your brain thinking, your heart beating, your cells growing--requires energy. Consequently, it comes as no surprise that disruptions in energy production can contribute to a wide range of diseases.

29 Aug 2018

Tips to know your ovarian cancer risk and symptoms

Ovarian cancer is the fifth leading cause of death in American women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. And according to the National Cancer Institute, approximately 22,240 women will be diagnosed with the disease in 2018; 14,070 will die from it.

28 Aug 2018

Researchers study motor, cognitive effects of DBS in patients with Parkinson's disease

Researchers from Charité - Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson's disease.

28 Aug 2018

Helping young patients gain more access to stroke preventive medications

People who survive a stroke in their 40s, 50s or early 60s may still have decades to live – but only if they take blood thinners, blood pressure drugs and other medications that can reduce their risk of a second stroke.

28 Aug 2018

Amphetamine regimen does not improve post-stroke motor recovery

A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.

27 Aug 2018

Researchers find new therapy to prevent drug resistance for melanoma patients

Mount Sinai researchers have discovered a previously unknown reason for drug resistance in a common subtype of melanoma, one of the deadliest forms of cancer, and in turn, have found a new therapy that could prevent or reverse drug resistance for melanoma patients with a particular gene mutation, according to a study published in Nature Communications in August.

24 Aug 2018

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

The Muscular Dystrophy Association today announced the award of 34 new grants totaling more than $9.9 million for its summer round of funding. These new grants represent a continued commitment by MDA to fund groundbreaking research that will accelerate treatments and cures for the more than 40 diseases in its program.

24 Aug 2018

Harvard scientists end 40-year-quest for elusive identity of 'hearing' protein

Scientists at Harvard Medical School say they have ended a 40-year-quest for the elusive identity of the sensor protein responsible for hearing and balance.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

Electrical stimulation of the brain and spinal cord may help treat the symptoms of rare movement disorders called neurodegenerative ataxias, according to a study published in the August 22, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Aug 2018

Researchers discover new subtype of multiple sclerosis

Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis, providing a better understanding of the individualized nature of the disease.

22 Aug 2018

BU professor receives $1.2 million grant to study impact of TBI, military service on Alzheimer's disease

Jesse Mez, MD, MS, assistant professor of neurology at Boston University School of Medicine, has received a three-year, $1.2 million grant from the United States Department of Defense to study the impact of traumatic brain injury and military service on Alzheimer's disease and related disorders.

20 Aug 2018

Neurology News and Research

Latest Neurology News and Research

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Presence of new or worsened bedsores associated with lower quality outcomes for rehab patients

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Rush University’s Ear, Nose and Throat program ranked top in three-state area

Study: First independent in-home use of brain-computer interface by ALS patients shows promise

SMA treatment may be effective even if started in children seven months and older

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Researchers enlist genes that control production of cellular energy stored in ATP molecules

Tips to know your ovarian cancer risk and symptoms

Researchers study motor, cognitive effects of DBS in patients with Parkinson's disease

Helping young patients gain more access to stroke preventive medications

Amphetamine regimen does not improve post-stroke motor recovery

Researchers find new therapy to prevent drug resistance for melanoma patients

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

Harvard scientists end 40-year-quest for elusive identity of 'hearing' protein

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

Researchers discover new subtype of multiple sclerosis

BU professor receives $1.2 million grant to study impact of TBI, military service on Alzheimer's disease

Everything you need to know about epilepsy eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Neurology News and Research

Latest Neurology News and Research

Everything you need to know about epilepsy eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in